Although foretinib was not evaluated, Kampen and collaborators had already shown that together both MEK and VEGFR-2 inhibition can induce cell death in a subset of KMT2A-r AML primary samples (Kampen et al., 2014). Here, MAP2K7 is linked to acute myeloid leukemia.